Mei Baisong bought EDIT

March 2, 2024 · Form 4 insider transaction

Mei Baisong bought 19,458 shares of Editas Medicine, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.

Direction
Acquired (buy-side)
Shares
19,458
Price
$0.00
Total value
N/A
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMarch 2, 2024
Filing dateMarch 5, 2024
Shares owned after142,413
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Reflects the vesting, upon the achievement of a specified research and development milestone, of a portion of a performance-based restricted stock unit award originally granted on July 18, 2022.

View the original Form 4 on SEC EDGAR